123 related articles for article (PubMed ID: 25956454)
1. Angiogenesis in salivary gland tumors: from clinical significance to treatment.
Theocharis S; Gribilas G; Giaginis C; Patsouris E; Klijanienko J
Expert Opin Ther Targets; 2015 Jun; 19(6):807-19. PubMed ID: 25956454
[TBL] [Abstract][Full Text] [Related]
2. An analysis of microvessel density in salivary gland tumours: a single centre study.
Dhanuthai K; Sappayatosok K; Yodsanga S; Rojanawatsirivej S; Pausch NC; Pitak-Arnnop P
Surgeon; 2013 Jun; 11(3):147-52. PubMed ID: 22878098
[TBL] [Abstract][Full Text] [Related]
3. Midkine expression in malignant salivary gland tumors and its role in tumor angiogenesis.
Ota T; Ota K; Jono H; Fujimori H; Ueda M; Shinriki S; Sueyoshi T; Shinohara M; Ando Y
Oral Oncol; 2010 Sep; 46(9):657-61. PubMed ID: 20637680
[TBL] [Abstract][Full Text] [Related]
4. Mammalian target of rapamycin pathway promotes tumor-induced angiogenesis in adenoid cystic carcinoma: its suppression by isoliquiritigenin through dual activation of c-Jun NH2-terminal kinase and inhibition of extracellular signal-regulated kinase.
Sun ZJ; Chen G; Zhang W; Hu X; Huang CF; Wang YF; Jia J; Zhao YF
J Pharmacol Exp Ther; 2010 Aug; 334(2):500-12. PubMed ID: 20484154
[TBL] [Abstract][Full Text] [Related]
5. Expression of caveolin-1 in mucoepidermoid carcinoma of the salivary glands: correlation with vascular endothelial growth factor, microvessel density, and clinical outcome.
Shi L; Chen XM; Wang L; Zhang L; Chen Z
Cancer; 2007 Apr; 109(8):1523-31. PubMed ID: 17342767
[TBL] [Abstract][Full Text] [Related]
6. Expressions of nuclear factor kappaB, inducible nitric oxide synthase, and vascular endothelial growth factor in adenoid cystic carcinoma of salivary glands: correlations with the angiogenesis and clinical outcome.
Zhang J; Peng B; Chen X
Clin Cancer Res; 2005 Oct; 11(20):7334-43. PubMed ID: 16243805
[TBL] [Abstract][Full Text] [Related]
7. The Impact of Angiogenesis in the Most Common Salivary Gland Malignant Tumors.
Pouloudi D; Sotiriadis A; Theodorakidou M; Sarantis P; Pergaris A; Karamouzis MV; Theocharis S
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33302367
[TBL] [Abstract][Full Text] [Related]
8. RANK and RANKL Expression in Salivary Gland Tumors.
Aslan F; Küçük Ü
Ear Nose Throat J; 2020 Aug; 99(7):475-480. PubMed ID: 32525717
[TBL] [Abstract][Full Text] [Related]
9. The VEGF pathway in lung cancer.
Alevizakos M; Kaltsas S; Syrigos KN
Cancer Chemother Pharmacol; 2013 Dec; 72(6):1169-81. PubMed ID: 24085262
[TBL] [Abstract][Full Text] [Related]
10. Extracellular matrix metalloproteinase inducer expression in salivary gland tumors: a correlation with microvessel density.
Huang ZQ; Chen WL; Li HG; Li JS; Xu ZY; Lin ZY
J Craniofac Surg; 2010 Nov; 21(6):1855-60. PubMed ID: 21119439
[TBL] [Abstract][Full Text] [Related]
11. [Clinico-pathological significance of microvessel density and vascular endothelial growth factor expression in adenoid cystic carcinoma of salivary glands].
Li Z; Tang P; Xu Z
Zhonghua Kou Qiang Yi Xue Za Zhi; 2001 May; 36(3):212-4. PubMed ID: 11812346
[TBL] [Abstract][Full Text] [Related]
12. [The relation of nuclear factor kappa B to angiogenesis and clinical outcomes in adenoid cystic carcinoma of salivary glands].
Zhang JL; Peng B; Chen XM
Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Nov; 40(6):495-9. PubMed ID: 16329838
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of oestrogen receptor-α and progesterone receptor in salivary gland tumours.
Kolude B; Adisa A; Adeyemi B; Lawal A
J Oral Pathol Med; 2013 Oct; 42(9):716-9. PubMed ID: 23601083
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor (VEGF) expression and microvascular density in salivary gland tumours.
Faur AC; Lazar E; Cornianu M
APMIS; 2014 May; 122(5):418-26. PubMed ID: 23937241
[TBL] [Abstract][Full Text] [Related]
15. Neovascularization: an attractive but tricky target in thyroid cancer.
Tasoulas J; Tsourouflis G; Theocharis S
Expert Opin Ther Targets; 2018 Sep; 22(9):799-810. PubMed ID: 30124087
[TBL] [Abstract][Full Text] [Related]
16. Assessing the in vivo efficacy of biologic antiangiogenic therapies.
Wilson PM; LaBonte MJ; Lenz HJ
Cancer Chemother Pharmacol; 2013 Jan; 71(1):1-12. PubMed ID: 23053262
[TBL] [Abstract][Full Text] [Related]
17. Expression of EMMPRIN in adenoid cystic carcinoma of salivary glands: correlation with tumor progression and patients' prognosis.
Yang X; Dai J; Li T; Zhang P; Ma Q; Li Y; Zhou J; Lei D
Oral Oncol; 2010 Oct; 46(10):755-60. PubMed ID: 20850374
[TBL] [Abstract][Full Text] [Related]
18. Angiogenesis in neuroendocrine tumors: therapeutic applications.
Scoazec JY
Neuroendocrinology; 2013; 97(1):45-56. PubMed ID: 22538258
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis inhibitors in early development for gastric cancer.
Pinto MP; Owen GI; Retamal I; Garrido M
Expert Opin Investig Drugs; 2017 Sep; 26(9):1007-1017. PubMed ID: 28770623
[TBL] [Abstract][Full Text] [Related]
20. Acinic cell carcinoma of the salivary glands: an immunohistochemical study of angiogenesis in 12 cases.
Mărgăritescu C; Munteanu MC; Niţulescu NC; Cionca L; Cotoi OS; Paskova G
Rom J Morphol Embryol; 2013; 54(2):275-84. PubMed ID: 23771070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
